November 19, 1998: Marc L. Berger, Merck & Co., Inc.

Response to AHRQ on CERTs

Responses received to a call for ideas and study topics for implementation of AHRQ's new demonstration program for grants to establish Centers for Education and Research on Therapeutics (CERTs).

Some preliminary thoughts:

  1. One CERT should focus on curriculum reform for health professionals... emphasizing systematic population management compared to a patient by patient approach.
  2. Another could focus on continuing medical education (CME)... how to make it more meaningful. Family practice requires recertification—does this do anything?
  3. One focus could be on how incentives and benefits can be structured to increase socially desirable medical decision making?
  4. Demonstration projects that show how to translate evidence into practice.
  5. Off-label drug use ... how do practitioners learn and communicate about uses of medications that are not approved?

Marc L. Berger, M.D.
Executive Director
Outcomes Research and Management
Merck & Co., Inc. WP 39-162
West Point, PA 19486
Phone: (215) 652-5861
Fax: (215) 652-0860
E-mail: marc_berger@merck.com

Disclaimer and Copyright

Return to Responses to AHCPR on CERTs

Current as of October 2012
Internet Citation: November 19, 1998: Marc L. Berger, Merck & Co., Inc.: Response to AHRQ on CERTs. October 2012. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/policy/foia/certs/cert6.html